Bunge stock rating reiterated as Buy by UBS with $100 price target

Published 11/08/2025, 13:48
Bunge stock rating reiterated as Buy by UBS with $100 price target

Investing.com - UBS has reiterated its Buy rating on Bunge (NYSE:BG) with a price target of $100.00.

The global investment firm maintained its positive outlook on the agricultural commodities trader and processor in a note issued Monday.

UBS analyst Manav Gupta kept the same price target that was previously set for the company, suggesting potential upside from current trading levels.

Bunge, headquartered in St. Louis, Missouri, operates as one of the world’s largest agribusiness and food companies, with operations spanning grain trading, oilseed processing, and food production.

The company has been navigating global agricultural market fluctuations and supply chain challenges while continuing its strategic focus on core business operations. According to InvestingPro analysis, Bunge maintains strong financial health with liquid assets exceeding short-term obligations and operates with a moderate level of debt. For deeper insights into Bunge’s financial metrics and growth potential, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.

In other recent news, Bunge Limited reported its Q2 2025 earnings, revealing a mixed financial performance. The company’s earnings per share (EPS) came in at $1.31, surpassing analyst forecasts of $1.14, marking a positive surprise of 14.91%. However, Bunge’s revenue for the quarter was $9.17 billion, which missed the expected $12.46 billion, indicating a significant shortfall of 26.4%. In addition to its earnings report, Bunge Global SA, a subsidiary of Bunge Limited, announced a public offering of $1.3 billion in senior unsecured notes. The offering is divided into two tranches: $650 million of 4.550% Senior Notes due 2030 and $650 million of 5.150% Senior Notes due 2035. These notes will be fully and unconditionally guaranteed by Bunge Global SA on a senior unsecured basis. These developments reflect Bunge’s strategic financial maneuvers amidst its recent earnings performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.